CRITIC/Independent expert: The Prime Minister is lying, the government's performance is not very good, but excellent!

 Kliko këtu për të tjera
Voxpress:

The trend that is shaking up cosmetic surgery

2026-07-14 14:31:03Lifestyle SHKRUAR NGA REDAKSIA VOX

This new cosmetic injection is causing controversy in the United States, as it uses fat tissue taken from deceased donors to restore volume in various areas of the body. The product is called alloClae and is a type of human fat that is processed, stabilized and packaged in syringes, ready for use.

Unlike synthetic or silicone fillers, alloClae is based on donated human fat tissue, which undergoes a process that removes the donor's DNA. The manufacturer, Tiger Aesthetics, promotes it as a "ready-made" alternative to aesthetic procedures, without the need for the patient to take fat from their own body.

The product was introduced to the US market in 2024 and was initially used only by board-certified plastic surgeons. Its use was later expanded to include nurse practitioners and medical assistants. According to the company, over 2,000 patients have been treated by 2025.

Demand increases after the use of weight loss drugs

One of the main reasons for the increase in interest in this procedure is related to the massive use of anti-obesity drugs, such as semaglutide and tirzepatide. These therapies have helped millions of people lose weight, but they have often also led to volume loss in areas such as the face, chest and buttocks. Doctors say that many patients seek to restore their previous appearance after rapid weight loss, making alloClae a new option in cosmetic surgery. 

The procedure is promoted as a quick procedure, also called a "lunchtime boob-job," as it takes less than an hour and usually does not require general anesthesia or hospitalization.

Safety concerns and side effects

However, experts have raised questions about the long-term safety of this technology. One of the main potential complications is fat necrosis, when the injected tissue is not properly supplied with blood and begins to deteriorate.

Some patients have reported pain, skin discoloration, lumps, and fluid leakage after the procedure. The company says there have been no confirmed cases of rejection or infection, but some surgeons are seeking more scientific data before using it widely.

Ethical debate: using donated bodies for profit

In addition to the medical issues, alloClae has also opened up an ethical debate. Critics argue that the commercial use of tissues taken from deceased persons could constitute a misuse of altruistic donation.

New York University bioethics professor Arthur Caplan has called this practice a "betrayal of the altruism of donors for profit."

Donor families do not receive payment and consent forms do not specifically mention the alloClae brand, only the use of tissues for commercial purposes.

Skepticism also from European doctors
In Europe and especially in Italy, doctors are more reserved. Plastic surgeon Roy De Vita emphasizes that fat is a complex tissue and that there is currently not enough evidence that fat taken from another person can function the same as autologous fat, that is, that taken from the patient himself.

According to him, the process of removing donor cells to make the tissue acceptable to the body raises scientific questions that have yet to be answered.

As the debate continues, alloClae is seen as an example of a new era of cosmetic surgery, where treatments become faster and more accessible, but at the same time open new questions about the boundaries between medical technology, the human body and ethics.


Në përputhje me standarded JTI

Video

SHIKO KANALIN NE YOUTUBE
×